another proof that Google is leading the digital health industry:
Yesterday Google made an announcement ("Now Google can help with updated health information") about the updates that the search engine is planning to integrate within the next five weeks as a follow up on the search explosion around the rare form of pneumonia outbreak that happened earlier last month. As part of the change, Google is planning to expand their medical conditions database and make it more accessible by taking a user straight to the conditions tab upon the search is performed. Over the next few weeks it is expected that Google's medical database will grow by almost 45% from 400 conditions to 900.
In the press release of September 2, the FDA announced that it has approved Varubi (rolapitant), the drug to soften the side effects from chemotherapy such as nausea and vomiting. These symptoms are common among patients undergoing chemical therapy. But aside from immediate side effects, Varubi aims to treat the delayed nausea and vomiting symptoms that tend to occur within 120 hours after the chemical treatment has been issued.
This is the second time Viagra is showing up in the news within the past few weeks, but this time Viagra is in a spotlight because of the re-branding efforts that Pfizer is implementing. The "Blue pill" is said to be soon available in a single package, which is supposed to make it more convenient to purchase and carry around. With the mission "A new way to take VIAGRA with you when you need it" the drug maker Pfizer is seizing an opportunity to present Viagra as a more portable and handy solution on the go.
The European Pharmaceutical Review Magazine has reported the results from the survey conducted by The Crown Records Management/Censuswide on data management. After surveying over 200 companies in the pharmaceutical sector, 60% of IT decision makers revealed that their company had lost important data. With the recent scandalous data breach of the Ashley Madison website, more and more key players in the pharma industry express their concerns over secure future of the doctor-patient data.
Stay tuned for our weekly news round up!
Subscribe to our Blog or follow us on Twitter: @epharma
About the author: Ksenia Newton, a Digital Marketing Assistant at IIR USA, Pharma Division, who works on various aspects of the industry including social media, marketing analysis and media. She can be reached at firstname.lastname@example.org